Quantcast
Last updated on April 19, 2014 at 21:20 EDT

Latest Ribbon symbolism Stories

2014-04-10 23:30:52

The Center for Diagnostic Imaging in Miami announces a new advancement in mammography screening. Miami, FL (PRWEB) April 10, 2014 The Center for Diagnostic Imaging in Miami announces a new advancement in mammography screening, 3D mammography. Detecting cancer in its earliest stages provides the best chance that it can be dealt with most effectively. Until recently, the best way to detect breast cancer was through the use of digital mammography. While digital mammography is still one of...

2014-04-10 23:29:55

Little Company of Mary Hospital honored for providing exceptional patient care and treatment. Evergreen Park, IL (PRWEB) April 10, 2014 Little Company of Mary Hospital has been named a recipient of the Women’s Choice Award as one of America’s Best Breast Centers, acknowledging its dedication to providing exceptional patient care and treatment. Breast cancer is the second most common form of cancer among American women according to the American Cancer Society, and one in eight women in...

2014-04-10 12:28:21

Revolutionary opto-acoustic technology may help physicians more accurately differentiate benign from cancerous breast masses SAN ANTONIO, April 10, 2014 /PRNewswire/ -- Seno Medical Instruments, Inc., the company pioneering the development of opto-acoustic technology as a new tool to improve the process of diagnosing breast cancer, announced today that it has received the CE Mark for Imagio(®), a new opto-acoustic imaging system, in Europe. Seno is in the middle of its Pivotal Study...

2014-04-10 08:28:33

DUBLIN, April 10, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/qxfqmk/drug_delivery_in) has announced the addition of a new report "Drug Delivery in Cancer - Technologies, Markets and Companies" [http://www.researchandmarkets.com/research/qxfqmk/drug_delivery_in ] to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Drug delivery remains a challenge in management of cancer. Approximately 12.5...

2014-04-09 08:29:49

SAN FRANCISCO, April 9, 2014 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR), a biopharmaceutical company developing novel therapeutics based on its PEGylation and advanced polymer conjugation technologies, today announced that preclinical data for NKTR-102 and NKTR-214 were presented at the 2014 Annual Meeting of the American Association of Cancer Research (AACR) being held in San Diego, California. NKTR-102 Presentation Positive preclinical data was presented for NKTR-102...

2014-04-08 23:33:19

Ohio Valley Medical Center honored for providing exceptional patient care and treatment. Wheeling, WV (PRWEB) April 08, 2014 Ohio Valley Medical Center received a Women’s Choice Award as one of America’s Best Breast Centers, acknowledging its dedication to providing exceptional patient care and treatment in the Ohio Valley. By carrying the Women’s Choice Award seal, OVMC has signified its commitment to a global mission to elevate the patient experience for women and all patients as...

2014-04-08 13:04:46

Trial identifies breast cancer patients likely to benefit from experimental drug In an innovative clinical trial led by UC San Francisco, the experimental drug neratinib along with standard chemotherapy was found to be a beneficial treatment for some women with newly diagnosed, high-risk breast cancer. Additionally, researchers learned that an algorithm used in the adaptive, randomized trial known as I-SPY 2 was highly effective at predicting the success of the treatment regimen in the...

2014-04-08 12:31:44

Metronomic algorithms for targeted therapy to improve value of response and "failed drugs" for "resistant women's cancers" NEW YORK, April 8, 2014 /PRNewswire/ -- The following will be presented this week at the annual meeting of the American Association of Cancer Research, San Diego. Dr Howard Bruckner will present accumulating evidence describing a novel successful treatment for patients with resistant ovarian cancer. Low dose chemotherapy as cores, selected drug combinations,...

2014-04-08 08:31:39

OICR's catalyst grant enables WaveCheck to open first partner site at MD Anderson Cancer Center in May TORONTO, April 8, 2014 /PRNewswire/ - People with breast cancer are a step closer to knowing if their tumour is responding to chemotherapy at the start of treatment, thanks to a $100,000 catalyst grant from the Ontario Institute for Cancer Research (OICR). The funding builds upon MaRS Innovation's Indiegogo crowdfunding campaign for WaveCheck, which successfully raised over...

2014-04-07 16:35:29

Women who have radiotherapy for breast cancer have a small but significantly increased risk of subsequently developing a primary lung tumour, and now research has shown that this risk increases with the amount of radiation absorbed by the tissue. Dr Trine Grantzau (MD) told the 33rd conference of the European Society for Radiotherapy and Oncology (ESTRO33) in Vienna: "We found that for each Gray delivered to the lung as part of radiotherapy for a breast tumour, the relative risk of...